While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains.

If approved, mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across the globe.

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the first single shot to ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...

The World Health Organization (WHO) today announced recommendations for the viral composition of influenza (or "flu") vaccines for the 2026-2027 northern hemisphere influenza season. The announcement ...

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.

The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...

Sanofi and Bavarian Nordics are amongst the recipients of contracts that will run for around eight years to help bring new products to market.

It’s unsurprising, but disappointing nonetheless: The president’s pick for surgeon general is a vaccine skeptic.